IMM 20.3% 35.5¢ immutep limited

nomura report target 32c, page-7

  1. 1,217 Posts.
    lightbulb Created with Sketch. 16
    If things turn out as we hope, that valuation will be blown out of the water if multiple Pharma's are interested as well as if we get FDA fast track to commercialisation. Dreaming I know but 32c would be an insult.
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.